ARTICLE | Management Tracks
Collins stepping down as Editas CEO, Mallon leaving Ironwood; plus Kite, Werewolf, Vedanta and more
February 9, 2021 3:00 AM UTC
Gene editing company Editas Medicine Inc. (NASDAQ:EDIT) said Chairman James Mullen will succeed Cynthia Collins as CEO after she steps down on Feb. 15. Collins had held the role since August 2019. Mullen, who was president and CEO of Biogen Inc. for a decade until 2010, has been Editas’ chairman since March 2018, and will continue in the role.
Mark Mallon will step down as CEO of Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD), effective March 12, to pursue another opportunity. President Thomas McCourt will be interim CEO while the gastrointestinal company seeks a permanent replacement. The company’s chair, Julie McHugh, will become executive chair...